Reproductive hormone regulation

Reproductive hormone regulation refers to the integrated physiological system, primarily the hypothalamic-pituitary-gonadal (HPG) axis, that controls sexual development and reproductive function (StatPearls, 2022). This process begins with the pulsatile secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which stimulates the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (NIH, 2021). These gonadotropins act on the gonads to promote the production of gametes and sex steroids like estrogen and testosterone, which in turn provide feedback to the brain to maintain homeostasis. Dysregulation of this regulatory network is a hallmark of various clinical conditions, including infertility, polycystic ovary syndrome (PCOS), and hormone-sensitive malignancies such as prostate and breast cancer (Mayo Clinic, 2023). While "Reproductive hormone regulation" is a biological process rather than a single molecular target, it encompasses numerous specific therapeutic targets such as the GnRH receptor and aromatase enzyme. Pharmacological interventions targeting this system are essential in managing reproductive health, contraception, and endocrine-related cancers (PubMed, 2019).

Other names

Hypothalamic-pituitary-gonadal axisHPG axisReproductive endocrine systemGonadal steroid regulation

Modulation of the HPG axis via agonism or antagonism of specific receptors (e.g., GnRHR, ER, AR) or inhibition of steroidogenic enzymes (e.g., Aromatase) to alter circulating levels of reproductive hormones.